Business
Growth & Innovation Forum 2020
Growth & Innovation Forum 2020.
About this update from Diaceutics Plc
[{"type":"text","content":"\n \nRNS Number : 1119C Diaceutics PLC 06 February 2020 \n\nDiaceutics PLC\n(\"Diaceutics\" or the \"Group\")\n \nGrowth & Innovation Forum 2020\n \nDiaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces it will be exhibiting at the Growth & Innovation Forum 2020 on Tuesday 11 February at the Business Design Centre, London.\n \nMembers of the Diaceutics management team will be at stand 23 throughout the day and Peter Keeling, CEO, will be presenting at 11.45am in the Babbage Room.\n \nThis is a one-day investor event where the exhibiting companies are focused on growth and technology. The show attracts both institutional and retail investors. For further information, please visit the event website at: https://www.sharesmagazine.co.uk/events/event/growth-innovation-forum-2020-1 \n \nEnquiries:\n \n\n\n\nDiaceutics PLC\n\n\nwww.diaceutics.com\n\n\n\n\nPeter Keeling, Chief Executive Officer\n\n\nVia Walbrook PR\n\n\n\n\nPhilip White, Chief Financial Officer\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nWalbrook PR\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\nMob: +44 (0)7876 741 001\n\n\n\n\nPaul McManus\n\n\nMob: +44 (0)7980 541 893\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nAbout Diaceutics\nDiaceutics PLC is a leading diagnostics data analytics and implementation services provider for global pharmaceutical companies. The Company, quoted on the Alternative Investment Market (AIM) of the London Stock Exchange, is enabling Pharma to accelerate their market penetration and achieve a better return on precision medicine therapies by helping them to revolutionise patient testing. By generating insights from its data lake of clinical laboratory testing data and other data, Diaceutics helps Pharma understand and leverage the diagnostic landscape through initiatives that improve patient testing, leading to better treatment outcomes. The Company works with more than 30 global pharmaceutical companies across hundreds of precision medicine projects. The Company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries. www.diaceutics.com\n \n \n \n\nThis information is provided by RNS, the news service of the London Stock Exc...